张静;高洁;武莎斐;鲁涛;梁智勇;
ZHANG Jing;GAO Jie;WU Sha-fei;LU Tao;LIANG Zhi-yong;Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

• 1:中国医学科学院北京协和医学院北京协和医院病理科

摘要(Abstract)：

目的探讨肾上腺嗜酸细胞型皮质癌临床病理特征及其表皮生长因子受体(epidermal growth factor receptor,EGFR)蛋白表达、基因突变和基因拷贝数改变情况。方法回顾性分析2000年1月至2009年12月在北京协和医院手术切除的9例肾上腺嗜酸细胞型皮质癌的临床特点、组织形态学特征,并以9例肾上腺嗜酸细胞型皮质腺瘤为对照,应用免疫组织化学、Scorpion ARMS突变系统及荧光原位杂交(fluorescence in situ hybridization,FISH)的方法分析EGFR在二者中的蛋白表达、基因突变和基因拷贝数改变的情况。结果 9例肾上腺嗜酸细胞型皮质癌中,Cushing综合征2例,无功能性皮质癌7例。病例随访时间6⁵6个月,皮质癌患者失访2例,死亡6例。肾上腺嗜酸细胞型皮质癌中EGFR蛋白过表达率为77.8%(7/9),EGFR FISH阳性率为55.6%(5/9);仅有22.2%(2/9)皮质腺瘤存在EGFR蛋白的表达,且EGFR FISH均为阴性。肾上腺嗜酸细胞型皮质腺瘤及皮质癌中均未检测出EGFR基因扩增及基因突变。结论肾上腺嗜酸细胞型皮质癌非常罕见,其诊断依据病理学及免疫表型,EGFR蛋白过表达和7号染色体的高多体性较腺瘤更常见,可能有助于与后者的鉴别诊断,也有可能成为今后临床分子靶向治疗的潜在方向。
Objective To explore the clinicopathological features of adrenocortical oncocytic carcinoma and protein expression,gene mutation,and gene copy number alteration of epidermal growth factor receptor( EGFR) in this carcinoma. Methods We reviewed the clinical and histomorphological features of 9 adrenocortical oncocytic carcinoma cases who received surgical resection in the period of January 2000 to December 2009 in Peking Union Medical College Hospital,and 9 adenoma cases were included as control. EGFR protein expression,EGFR gene mutation and EGFR gene copy number alteration in both groups were detected by immunohistochemistry,Scorpion Amplification Refractory Mutation System( ARMS),and fluorescence in situ hybridization( FISH),respectively. Results The 9 cases of adrenocortical oncocytic carcinomas included 2 cases of Cushing's syndrome and 7 cases of nonfunctional cortical carcinoma. All cases were followed up for 6 to 56 months,and 2 patients with adrenocortical oncocytic carcinomas lost to follow-up,and 6 died. In the adrenocorti-cal oncocytic carcinoma patients,EGFR overexpression was found in 77. 8%( 7 /9),and EGFR FISH was positive in 55. 6%( 5 /9). In contrast,only 22. 2%( 2 /9) of the adrenocortical adenoma patients showed EGFR weak expression and none had positive FISH result. No EGFR gene amplification or mutation was found in the 2groups of patients. Conclusions Adrenocortical oncocytic carcinoma is rare. EGFR overexpression and chromosome 7 polysomy are frequent abnormality in the adrenocortical oncocytic carcinomas,which may be used in the differential diagnosis. Also,an investigation of the gene status of EGFR should facilitate the identification of a target therapeutic regimen for carcinoma patients.

关键词(KeyWords)： 肾上腺嗜酸细胞型皮质癌;表皮生长因子受体;免疫组化;荧光原位杂交;基因突变
adrenocortical oncocytic carcinoma;epidermal growth factor receptor;immunohistochemistry;fluorescence in situ hybridization;gene mutation

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 张静;高洁;武莎斐;鲁涛;梁智勇;
ZHANG Jing;GAO Jie;WU Sha-fei;LU Tao;LIANG Zhi-yong;Department of Pathology,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences &Peking Union Medical College;

参考文献(References)：

• [1]Wong DD,Spagnolo DV,Bisceglia M,et al.Oncocytic adrenocortical neoplasms-a clinicopathologic study of 13 new cases emphasizing the importance of their recognition[J].Hum Pathol,2011,42:489-499.
• [2]Ohtake H,Kawamura H,Matsuzaki M,et al.Oncocytic adrenocortical carcinoma[J].Ann Diagn Pathol,2010,14:204-208.
• [3]Thway K,Olmos D,Shah C,et al.Oncocytic adrenal cortical carcinosarcoma with pleomorphic rhabdomyosarcomatous metastases[J].Am J Surg Pathol,2012,36:470-477.
• [4]Bisceglia M,Ludovico O,Di Mattia A,et al.Adrenocortical oncocytic tumors:report of 10 cases and review of the literature[J].Int J Surg Pathol,2004,12:231-243.
• [5]Song SY,Park S,Kim SR,et al.Oncocytic adrenocortical carcinomas:a pathological and immunohistochemical study of four cases in comparison with conventional adrenocortical carcinomas[J].Pathol Int,2004,54:603-610.
• [6]Hoang MP,Ayala AG,Albores-Saavedra J.Oncocytic adrenocortical carcinoma:a morphologic,immunohistochemical and ultrastructural study of four cases[J].Mod Pathol,2002,15:973-978.
• [7]Mearini L,Del Sordo R,Costantini E,et al.Adrenal oncocytic neoplasm:a systematic review[J].Urol Int,2013,91:125-133.
• [8]Erickson LA,Rivera M,Zhang J.Adrenocortical carcinoma:review and update[J].Adv Anat Pathol,2014,21:151-159.
• [9]许敬平,吴大为,黄江梅,等.肾上腺皮质嗜酸细胞癌7例临床病理分析[J].临床与实验病理学杂志,2013,29:765-767.
• [10]潘敏鸿,张新华,马恒辉,等.肾上腺嗜酸细胞型皮质癌临床病理观察[J].诊断病理学杂志,2007,14:423-426.
• [11]Normanno N,De Luca A,Bianco C,et al.Epidermal growth factor receptor(EGFR)signaling in cancer[J].Gene,2006,366:2-16.
• [12]Sibilia M,Kroismayr R,Lichtenberger BM,et al.The epidermal growth factor receptor:from development to tumorigenesis[J].Differentiation,2007,75:770-787.
• [13]Adam P,Hahner S,Hartmann M,et al.Epidermal growth factor receptor in adrenocortical tumors:analysis of gene sequence,protein expression and correlation with clinical outcome[J].Mod Pathol,2010,23:1596-1604.
• [14]Zhang J,Wang C,Liang Z,et al.Adrenal cortical neo-plasms:a study of clinicopathological features related to epidermal growth factor receptor gene status[J].Diagn Pathol,2014,9:19.
• [15]Cappuzzo F,Hirsch FR,Rossi E,et al.Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer[J].J Natl Cancer Inst,2005,97:643-655.
• [16]Weiss LM,Medeiros LJ,Vickery AL.Pathologic features of prognostic significance in adrenocortical carcinoma[J].Am J Surg Pathol,1989,13:202-206.
• [17]Kamio T,Shigematsu K,Sou H,et al.Immunohistochemical expression of epidermal growth factor receptors in human adrenocortical carcinoma[J].Hum Pathol,1990,21:277-282.
• [18]Nakamura M,Miki Y,Akahira J,et al.An analysis of potential surrogate markers of target-specific therapy in archival materials of adrenocortical carcinoma[J].Endocr Pathol,2009,20:17-23.
• [19]Kotoula V,Sozopoulos E,Litsiou H,et al.Mutational analysis of the BRAF,RAS and EGFR genes in human adrenocortical carcinomas[J].Endocr Relat Cancer,2009,16:565-572.